Home  |  Top News  |  Most Popular  |  Video  |  Multimedia  |  News Feeds  |  Feedback
  Medicine  |  Nature & Earth  |  Biology  |  Technology & Engineering  |  Space & Planetary  |  Psychology  |  Physics & Chemistry  |  Economics  |  Archaeology
Top > Medicine, Health Care > Breast Cancer Drug Fights Fungal… >

Breast Cancer Drug Fights Fungal Disease

Published: February 11, 2014.
Released by American Society for Microbiology  

Tamoxifen, a drug currently used to treat breast cancer, also kills a fungus that causes a deadly brain infection in immunocompromised patients. The findings, which could lead to new treatments for a disease that kills more HIV/AIDS patients than tuberculosis, appear in mBio¼/i>, the online open-access journal of the American Society for Microbiology (ASM.)

"This work sets the stage for additional animal studies to see if tamoxifen can be used as a drug in people and will allow us to design new drugs related to tamoxifen that are better antifungals," says Damian Krysan of the University of Rochester, an author on the study.

Cryptococcosis is one of the most prevalent human fungal infections, responsible for approximately 1 million new infections and 620,000 deaths worldwide each year. The disease strikes primarily people living with HIV/AIDS and causes more deaths in this population than tuberculosis. It manifests as either pneumonia or a brain infection known as meningoencephalitis.

"The gold standard therapy for this infection is a combination of amphotericin B and 5-flucytosine. These drugs were first used in the late 1950s when penicillin was the antibiotic of choice. There have been no substantial improvements in the treatment of this disease in a half-century and the therapy is not available in many regions of the world that need it most," says Krysan.

In areas of the world where the gold-standard therapy is not available, like sub-Saharan Africa, the drug of choice is fluconazole because it is widely available and inexpensive. Unfortunately, it is much less effective since it does not actually kill the fungus.

"Recently, interest in re-using old drugs to treat new diseases has increased as a way to develop new therapies more quickly. We screened a large collection of old drugs for drugs that kill Cryptococcus and rediscovered tamoxifen," says Krysan. "We used clinical microbiology tests to determine whether the molecules had promising activity against Cryptococcus both alone and in combination with other antifungal drugs such as fluconazole. The combination of tamoxifen and fluconazole was synergistic; this means that the combination is more than 4-times more active than either alone."

Krysan and his colleagues also demonstrated that tamoxifen does not kill the fungus in the same way it works against breast cancer. Instead, it inhibits proteins related to calmodulin, an important calcium binding protein. They found that by making modifications to tamoxifen that improve its ability to interfere with calmodulin, they also improved its ability to kill Cryptococcus.

"An effective, widely available treatment for cryptococcal meningitis is an unmet clinical need of global importance," says Krysan. "These results indicate that tamoxifen is a pharmacologically attractive scaffold for the development of new anti-cryptococcal drugs and provide a mechanistic base for its further optimization."




The above story is based on materials provided by American Society for Microbiology.

Translate this page: Chinese French German Italian Japanese Korean Portuguese Russian Spanish


comments powered by Disqus


Related »

Tamoxifen 
12/11/14 
New Evidence Reveals Tamoxifen Reduces Breast Cancer Rates by Nearly a Third for 20 Years
The preventive effect of breast cancer drug 'tamoxifen' remains virtually constant for at least 20 years - with rates …
Patients 
11/16/11 
Male Breast Cancer Patients Stop Taking Tamoxifen Early Because of Drug-related Side Effects
The largest study to investigate the tolerability of the breast cancer drug tamoxifen in male breast cancer patients has …
Tamoxifen 
4/22/13 
Mammograms Reveal Response to Common Cancer Drug
Researchers at Karolinska Institutet have developed a method for assessing the effect of tamoxifen, a common drug to prevent …
Cancer 
10/31/12 
Scientists Unravel Resistance to Breast Cancer Treatment
Scientists have identified a molecular 'flag' in women with breast cancer who do not respond or have become resistant …
Tamoxifen 
4/18/13 
Cold Winters Freezing Out Breast Cancer Treatment
LONDON, ON – For women diagnosed with a form of breast cancer known as estrogen receptor positive (ER+) breast …
Tamoxifen 
11/16/11 
★ 
Tamoxifen Causes Significant Side Effects in Male Breast Cancer Patients
About half of male breast cancer patients who take the drug tamoxifen to prevent their disease from returning report …
Breast 
12/6/12 
Tamoxifen Trial Should Prompt Breast Cancer Patients to Reconsider Treatment Options
MAYWOOD, Il. - A groundbreaking clinical trial involving the breast cancer drug tamoxifen should prompt certain breast cancer patients …
Tamoxifen 
12/7/11 
Researchers Discover Patterns of Genes Associated with Timing of Breast Cancer Recurrences
An international research team led by Georgetown Lombardi Comprehensive Cancer Center has found biological differences in hormone-receptor positive breast …
More » 
 
© Newsline Group  |  About  |  Privacy Policy  |  Feedback  |  Mobile